Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FZMZ5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,332
Award facts
- Contract value 100% obligated
- $8,331.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,331.60 to DMS Pharmaceutical Group Inc. on September 12, 2025, for the supply of Nexplanon 68 mg implants, with an ultimate completion date of October 3, 2025. This firm fixed-price delivery order was issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, a $499.999 billion contract vehicle valued through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products for Department of Defense healthcare facilities. The contract carries no set-aside designation, allowing the woman-owned small business to compete on an unrestricted basis. The place of performance is Park Ridge, Illinois, where DMS Pharmaceutical Group is headquartered.
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler registered in SAM.gov since 2001, serves as the prime contractor with no identified subcontractors on this delivery order. The company specializes in distributing branded and generic prescription drugs, biologics, and medical consumables to federal healthcare systems, with a demonstrated portfolio of contracts covering contraceptive devices, oncology treatments, vaccines, and specialty pharmaceutical products. This delivery order for Nexplanon implants—a subdermal contraceptive device—represents part of the company's ongoing role as a critical supplier within the federal pharmaceutical supply chain supporting military health facilities nationwide.
Quick answers
Who was awarded contract SPE2DB25FZMZ5?
SPE2DB25FZMZ5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 12, 2025.
How much is contract SPE2DB25FZMZ5 worth?
The government has obligated $8,332 on SPE2DB25FZMZ5.
Is contract SPE2DB25FZMZ5 an order under another contract?
Yes. SPE2DB25FZMZ5 is a delivery order under SPE2DB24D9210, an indefinite delivery contract.
Was contract SPE2DB25FZMZ5 competed?
The extent of competition for SPE2DB25FZMZ5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award